ITMCTR2200005691尚未招募4 期
A prospective, multicenter, randomized, open parallel controlled clinical trial of Tongren Wuji Baifeng Pill in the treatment of hyperuricemia in patients with chronic kidney disease
适应症
试验速览
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional study
入排标准
- 年龄范围
- 18 至 70(—)
- 性别
- All
入选标准
- •(1) Age 18-70 years old, regardless of gender
- •(2) Patients meeting the diagnostic criteria for CKD and staged as CKD stage 2-4 (15 ml/min.1.73m2=GFR<90 ml/min.1.73m2)
- •(3) Meeting the diagnostic criteria of hyperuricemia
- •(4) Patients with evidence of spleen and kidney deficiency and blood deficiency with stasis
- •(5) Signed informed consent form
排除标准
- •(1) Taking one or more of the Western medicine uric acid-lowering drugs, such as allopurinol, benzbromarone, probenecid, febuxostat, etc. within the last 1 month
- •(2) Uncontrollable hypertension/hypotension: systolic blood pressure = 200 mmHg or diastolic blood pressure = 110 mmHg; or systolic blood pressure = 90 mmHg or diastolic blood pressure = 60 mmHg
- •(3) Change in blood creatinine level of more than 50% in the last 3 months
- •(4) Combination of various acute infections, or with severe infections, severe anaemia, etc.
- •(5) History or complications of malignancy
- •(6) Organic heart disease, such as congenital heart disease, rheumatic heart disease, etc.
- •(7) Severe liver function abnormalities (ALT or AST greater than 3 times the upper limit of normal)
- •(8) Pregnant or lactating women
- •(9) Participating in any other clinical trial
- •(10) Any other reason why the investigator considers it inappropriate to participate in this study
研究者
相似试验
进行中(未招募)
不适用
An open randomised, prospective, multi-centre, parallel-group trial to compare efficacy and safety of TachoSil versus standard surgical treatment in patients undergoing pulmonary lobectomy for lung malingnancy and requiring treatment for air leakage. - TachoSil versus standard surgical treatment for air leakage in pulmonary lobectomyManagement of pulmonary air leakage following lobectomy in subjects with lung malignancies including metastases.MedDRA version: 8.1Level: PTClassification code 10024741EUCTR2004-002380-24-HUycomed Danmark ApS, International Medical Affairs300
进行中(未招募)
不适用
An open randomised, prospective, multi-centre, parallel-group trial to compare efficacy and safety of TachoSil versus standard surgical treatment in patients undergoing pulmonary lobectomy for lung malingnancy and requiring treatment for air leakage. - TachoSil versus standard surgical treatment for air leakage in pulmonary lobectomyManagement of pulmonary air leakage following lobectomy in subjects with lung malignancies including metastases.MedDRA version: 8.1Level: PTClassification code 10024741EUCTR2004-002380-24-BEycomed Danmark ApS, International Medical Affairs300
进行中(未招募)
不适用
An open randomised, prospective, multi-centre, parallel-group trial to compare efficacy and safety of TachoSil versus standard surgical treatment in patients undergoing pulmonary lobectomy for lung malingnancy and requiring treatment for air leakage. - TachoSil versus standard surgical treatment for air leakage in pulmonary lobectomyManagement of pulmonary air leakage following lobectomy in subjects with lung malignancies including metastases.MedDRA version: 8.1Level: PTClassification code 10024741EUCTR2004-002380-24-DEycomed Danmark ApS, International Medical Affairs300
进行中(未招募)
不适用
An open randomised, prospective, multi-centre, parallel-group trial to compare efficacy and safety of TachoSil versus standard surgical treatment in patients undergoing pulmonary lobectomy for lung malingnancy and requiring treatment for air leakage. - TachoSil versus standard surgical treatment for air leakage in pulmonary lobectomyEUCTR2004-002380-24-SEycomed Danmark ApS, International Medical Affairs300
进行中(未招募)
不适用
An open randomised, prospective, multi-centre, parallel-group trial to compare efficacy and safety of TachoSil versus standard surgical treatment in patients undergoing pulmonary lobectomy for lung malingnancy and requiring treatment for air leakage. - TachoSil versus standard surgical treatment for air leakage in pulmonary lobectomyManagement of pulmonary air leakage following lobectomy in subjects with lung malignancies including metastases.MedDRA version: 8.1Level: PTClassification code 10024741EUCTR2004-002380-24-ATycomed Danmark ApS, International Medical Affairs300
